Report cover image

RNA Targeting Small Molecule Drug Discovery Global Market Report 2025

Publisher The Business Research Company
Published Feb 28, 2025
Length 200 Pages
SKU # BRC19655245

Description

RNA Targeting Small Molecule Drug Discovery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rna targeting small molecule drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for rna targeting small molecule drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rna targeting small molecule drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Target RNA Type: Messenger RNA (mRNA); Non-Coding RNA (ncRNA); MicroRNA (miRNA); Long Non-Coding RNA (lncRNA)

2) By Technology: CRISPR-Cas9; RNA Aptamers; Small Interfering RNA (siRNA); Ribozymes; Other Technologies

3) By Therapeutic Area: Oncology; Neurology; Infectious Disease; Metabolic Diseases; Genetic Disorders; Other Therapeutic Areas

4) By Delivery Method: Intravenous (IV); Oral; Topical; Other Methods

5) By Application: Research Use; Therapeutic Use; Diagnostic Use; Other Applications

Subsegments:

1) By Messenger RNA (mRNA): Targeting mRNA For Protein Coding; Modulation Of mRNA Stability; mRNA Translation Inhibition

2) By Non-Coding RNA (ncRNA): Long Non-Coding RNA; Small Nuclear RNA; Small Nucleolar RNA

3) By MicroRNA (miRNA): miRNA Inhibition; miRNA Mimics; Targeting Specific miRNA Pathways

4) By Long Non-Coding RNA (lncRNA): lncRNA Modulators; Targeting Specific lncRNA Functions; Therapeutic Applications Of lncRNA

Companies Mentioned: F. Hoffmann-La Roche Ltd; Merck & Co. Inc; Bayer AG; Novartis AG; Sanofi SA

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

200 Pages
1. Executive Summary
2. RNA Targeting Small Molecule Drug Discovery Market Characteristics
3. RNA Targeting Small Molecule Drug Discovery Market Trends And Strategies
4. RNA Targeting Small Molecule Drug Discovery Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global RNA Targeting Small Molecule Drug Discovery Growth Analysis And Strategic Analysis Framework
5.1. Global RNA Targeting Small Molecule Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global RNA Targeting Small Molecule Drug Discovery Market Growth Rate Analysis
5.4. Global RNA Targeting Small Molecule Drug Discovery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global RNA Targeting Small Molecule Drug Discovery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global RNA Targeting Small Molecule Drug Discovery Total Addressable Market (TAM)
6. RNA Targeting Small Molecule Drug Discovery Market Segmentation
6.1. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Messenger RNA (mRNA)
Non-Coding RNA (ncRNA)
MicroRNA (miRNA)
Long Non-Coding RNA (lncRNA)
6.2. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR-Cas9
RNA Aptamers
Small Interfering RNA (siRNA)
Ribozymes
Other Technologies
6.3. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Neurology
Infectious Disease
Metabolic Diseases
Genetic Disorders
Other Therapeutic Areas
6.4. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous (IV)
Oral
Topical
Other Methods
6.5. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research Use
Therapeutic Use
Diagnostic Use
Other Applications
6.6. Global RNA Targeting Small Molecule Drug Discovery Market, Sub-Segmentation Of Messenger RNA (mRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeting mRNA For Protein Coding
Modulation Of mRNA Stability
mRNA Translation Inhibition
6.7. Global RNA Targeting Small Molecule Drug Discovery Market, Sub-Segmentation Of Non-Coding RNA (ncRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Long Non-Coding RNA
Small Nuclear RNA
Small Nucleolar RNA
6.8. Global RNA Targeting Small Molecule Drug Discovery Market, Sub-Segmentation Of MicroRNA (miRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
miRNA Inhibition
miRNA Mimics
Targeting Specific miRNA Pathways
6.9. Global RNA Targeting Small Molecule Drug Discovery Market, Sub-Segmentation Of Long Non-Coding RNA (lncRNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
lncRNA Modulators
Targeting Specific lncRNA Functions
Therapeutic Applications Of lncRNA
7. RNA Targeting Small Molecule Drug Discovery Market Regional And Country Analysis
7.1. Global RNA Targeting Small Molecule Drug Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global RNA Targeting Small Molecule Drug Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market
8.1. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China RNA Targeting Small Molecule Drug Discovery Market
9.1. China RNA Targeting Small Molecule Drug Discovery Market Overview
9.2. China RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India RNA Targeting Small Molecule Drug Discovery Market
10.1. India RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan RNA Targeting Small Molecule Drug Discovery Market
11.1. Japan RNA Targeting Small Molecule Drug Discovery Market Overview
11.2. Japan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia RNA Targeting Small Molecule Drug Discovery Market
12.1. Australia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia RNA Targeting Small Molecule Drug Discovery Market
13.1. Indonesia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea RNA Targeting Small Molecule Drug Discovery Market
14.1. South Korea RNA Targeting Small Molecule Drug Discovery Market Overview
14.2. South Korea RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe RNA Targeting Small Molecule Drug Discovery Market
15.1. Western Europe RNA Targeting Small Molecule Drug Discovery Market Overview
15.2. Western Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK RNA Targeting Small Molecule Drug Discovery Market
16.1. UK RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany RNA Targeting Small Molecule Drug Discovery Market
17.1. Germany RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France RNA Targeting Small Molecule Drug Discovery Market
18.1. France RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy RNA Targeting Small Molecule Drug Discovery Market
19.1. Italy RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain RNA Targeting Small Molecule Drug Discovery Market
20.1. Spain RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market
21.1. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market Overview
21.2. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia RNA Targeting Small Molecule Drug Discovery Market
22.1. Russia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America RNA Targeting Small Molecule Drug Discovery Market
23.1. North America RNA Targeting Small Molecule Drug Discovery Market Overview
23.2. North America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA RNA Targeting Small Molecule Drug Discovery Market
24.1. USA RNA Targeting Small Molecule Drug Discovery Market Overview
24.2. USA RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada RNA Targeting Small Molecule Drug Discovery Market
25.1. Canada RNA Targeting Small Molecule Drug Discovery Market Overview
25.2. Canada RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America RNA Targeting Small Molecule Drug Discovery Market
26.1. South America RNA Targeting Small Molecule Drug Discovery Market Overview
26.2. South America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil RNA Targeting Small Molecule Drug Discovery Market
27.1. Brazil RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East RNA Targeting Small Molecule Drug Discovery Market
28.1. Middle East RNA Targeting Small Molecule Drug Discovery Market Overview
28.2. Middle East RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa RNA Targeting Small Molecule Drug Discovery Market
29.1. Africa RNA Targeting Small Molecule Drug Discovery Market Overview
29.2. Africa RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. RNA Targeting Small Molecule Drug Discovery Market Competitive Landscape And Company Profiles
30.1. RNA Targeting Small Molecule Drug Discovery Market Competitive Landscape
30.2. RNA Targeting Small Molecule Drug Discovery Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
31. RNA Targeting Small Molecule Drug Discovery Market Other Major And Innovative Companies
31.1. Bristol-Myers Squibb Company
31.2. AstraZeneca PLC
31.3. Takeda Pharmaceutical Company Limited
31.4. Eli Lilly and Company
31.5. Amgen Inc.
31.6. Moderna Inc.
31.7. Astellas Pharma Inc.
31.8. Biogen Inc.
31.9. Alnylam Pharmaceuticals Inc.
31.10. Sarepta Therapeutics Inc.
31.11. Evotec A.G.
31.12. PTC Therapeutics Inc.
31.13. Ionis Pharmaceuticals Inc.
31.14. Dicerna Pharmaceuticals Inc.
31.15. Arrakis Therapeutics
32. Global RNA Targeting Small Molecule Drug Discovery Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The RNA Targeting Small Molecule Drug Discovery Market
34. Recent Developments In The RNA Targeting Small Molecule Drug Discovery Market
35. RNA Targeting Small Molecule Drug Discovery Market High Potential Countries, Segments and Strategies
35.1 RNA Targeting Small Molecule Drug Discovery Market In 2029 - Countries Offering Most New Opportunities
35.2 RNA Targeting Small Molecule Drug Discovery Market In 2029 - Segments Offering Most New Opportunities
35.3 RNA Targeting Small Molecule Drug Discovery Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us